Breast Cancer? Put It on Ice
A Lump in the Road - A Column by Nancy Brier, Columns
The bad news? It was cancer. The good news? It was in the early stages, a baby tumor at 1.5 cm. It’s hard to believe something so small has such ... Read more
Antibody-Drug Conjugate Shows Efficacy in Heavily Treated Cancers
News
An investigational antibody-drug conjugate made of the HER2-targeting antibody trastuzumab (marketed as Herceptin and others) attached to a kind of chemotherapy compound has demonstrated notable efficacy in heavily treated patients ... Read more
Genomic Analysis Reveals Differences Between Cancer Cell Lines and Human Cancers
News
New research using “big data” helps highlight the differences between breast cancer cell lines and actual patient samples. This could allow researchers to choose models that more accurately reflect what ... Read more
Trilaciclib-Chemo Combo Extends Lives of Triple-negative Breast Cancer Patients, Preliminary Phase 2 Findings Show
News
Trilaciclib, a treatment that protects the bone marrow from the damaging effects of chemotherapy, significantly extends the lives of women with metastatic triple-negative breast cancer receiving a chemotherapy regimen of ... Read more
What Cancer Taught Me About Being a Mom
A Lump in the Road - A Column by Nancy Brier, Columns
I dated a guy in college who described the time he saw a nasty brown stain on his shower floor. When he called his mother, she explained that he would ... Read more
$20M Gift to Dana-Farber Will Establish Fund for Metastatic Breast Cancer Research
News
The Dana-Farber Cancer Institute will get $20 million to create the Saverin Breast Cancer Research Fund aimed at extending the lives of metastatic breast cancer patients. The gift from the ... Read more
Balixafortide-Halaven Combo Seen to Prolong Survival in Advanced Breast Cancer Patients in Phase 1 Trial
News
A combination of Polyphor‘s investigational therapy balixafortide (POL6326) and Eisai‘s Halaven (eribulin) may prolong the survival of women with HER2-negative metastatic breast cancer, a Phase 1 trial shows. The findings were ... Read more
Obesity Reprograms Immune Cells in Mammary Tissues to Promote Tumor Development, Study Says
News
Obesity in women with triple-negative breast cancer, the most aggressive kind of breast cancer, reprograms immune cells and creates a chronic inflammatory environment that promotes cancer progression and spread, a ... Read more
Puma Applies to FDA to Extend Nerlynx’s Use to HER2-Positive Metastatic Breast Cancer
News
Puma Biotechnology is seeking to extend the use of its breast cancer medicine Nerlynx (neratinib), in combination with capecitabine, to treat women with HER2-positive breast cancer whose disease has spread ... Read more
CHMP Recommends Tecentriq-Abraxane Combination to Treat Some Triple-negative Breast Cancers in Europe
News
The Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines Agency , has recommended the approval of Tecentriq (atezolizumab) in combination with the chemotherapy Abraxane (nab-paclitaxel) as a ... Read more
Survival Is All About the Money
A Lump in the Road - A Column by Nancy Brier, Columns
“It’s cancer,” my friend said. She had seen a doctor for something unrelated, but now she’s freaking out. Mostly about the money. The tumor they found in her right breast ... Read more
Fujifilm Bus Hits the Road to Offer Breast Cancer Screenings and Promote Early Diagnosis
News
Fujifilm Medical Systems USA has launched a nationwide effort to enhance access to breast cancer screening and raise awareness about the importance of early disease detection. Called “Aspire to Be ... Read more